NASDAQ : PTC

PTC Inc. — News

$120.77 USD

-$4.06 (-3.25%)

Volume
1.85M
Average Volume
1.74M
Market Capitalization
$13.95B
P/E Ratio
11.48
Dividend Yield
0.00%
Price Target
$189.00
Year High
$219.69
Year Low
$108.50
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$1.06
Source Headline
Bank of New York Mellon Corp Trims Stake in PTC Inc. $PTC

Bank of New York Mellon Corp reduced its stake in PTC Inc. (NASDAQ: PTC) by 2.9% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 662,973 shares of the technology company's stock after selling 19,621 shares during the quarter. Bank of New

defenseworld.net - 2026-07-21 04:21:07

PTC Targets ALM Growth as Codebeamer Gains Traction in Software-Defined Products

PTC (NASDAQ: PTC) used a partner webinar to outline what executives described as a significant growth opportunity in application lifecycle management, or ALM, driven by increasingly software-defined products, regulatory demands and the need for large enterprises to modernize engineering processes. Oliver Becker, a member of PTC's alliance management team focused on the company's ALM solutions portfolio,

defenseworld.net - 2026-07-17 05:13:43

PTC Windchill Named a Leader and PTC Arena Named a Visionary in Gartner Magic Quadrant for PLM Software in Discrete Manufacturing Industries

BOSTON, July 16, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced it has been named a Leader in the 2026 Gartner® Magic Quadrant™ for PLM Software in Discrete Manufacturing Industries for its Windchill® product lifecycle management (PLM) solution, and a Visionary for its Arena® product lifecycle management (PLM) and quality management system (QMS) solution. With Windchill, PTC is positioned highest on the "Ability to Execute" evaluation criteria, which include product and service, overall viability, market responsiveness, and customer experience.

prnewswire.com - 2026-07-16 08:30:00

PTC Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, July 30, 2026

WARREN, N.J., July 16, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today that the company will host a webcast conference call to report its second quarter 2026 financial results and provide an update on the company's business and outlook on Thursday, July 30, 2026, at 4:30 p.m.

prnewswire.com - 2026-07-16 08:00:00

PTC Inc. (PTC) Discusses Unlocking Business Value and Growth Opportunities in Modern ALM Prepared Remarks Transcript

PTC Inc. (PTC) Discusses Unlocking Business Value and Growth Opportunities in Modern ALM Prepared Remarks Transcript

seekingalpha.com - 2026-07-15 21:37:59

PTC Targets ALM Growth as Codebeamer Gains Traction in Software-Defined Products

PTC NASDAQ: PTC used a partner webinar to outline what executives described as a significant growth opportunity in application lifecycle management, or ALM, driven by increasingly software-defined products, regulatory demands and the need for large enterprises to modernize engineering processes.

marketbeat.com - 2026-07-15 14:02:58

Rambam Health Care Campus, EOS and PTC Partner to Establish Advanced In-House Digital Implant Engineering Center

HAIFA, Israel and KRAILLING, Germany and BOSTON, July 15, 2026 /PRNewswire/ -- Rambam Health Care Campus, EOS, and PTC today announced collaboration to establish a Digital Implant Engineering Center at Rambam in Haifa, Israel. A dedicated team of engineers and physicians plan to work together to design, develop, and produce customized patient implants and devices using metal 3D printing.

prnewswire.com - 2026-07-15 08:00:00

PTC Introduces Onshape Labs to Accelerate AI Inside the Product Development Process

Launches early-access program, with broader availability expected later this summer via opt-in access Enables participating customers to evaluate emerging Onshape capabilities earlier in the development cycle Applies advanced technologies within engineering workflows, using real-time product data to power automation and improve design decisions BOSTON, July 14, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the Onshape Labs™ initiative, a new early-access program within its Onshape® cloud-native CAD and PDM platform that gives participating customers a first look at emerging functionalities, including new uses of AI, delivered directly inside the product development workflow. Broader availability is expected later this summer, when users will be able to opt in through the Onshape "Preferences" settings under "Onshape Labs.

prnewswire.com - 2026-07-14 08:30:00

What This PTC Therapeutics Insider Sale Means as Product Revenue Hit $226 Million

The transaction generated $222,376 in gross proceeds, realized through the exercise of 2,464 options at $46.54 and their immediate sale at a weighted average price of $90.25. The disposition represented 4% of the insider's direct common stock holdings.

fool.com - 2026-07-13 19:28:52

Reasons Why Investors Should Consider Betting on PTC Stock Now

PTCT's rare disease portfolio expands as Sephience sales surge, while late-stage pipeline programs add new growth opportunities.

zacks.com - 2026-07-10 15:16:06

PTC to Announce Fiscal Q3'26 Results on Wednesday, July 29, 2026

BOSTON, July 8, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) will release its fiscal 2026 third quarter results on Wednesday, July 29th after the stock market closes. Senior management will host a live webcast and conference call to review the results on Wednesday, July 29th at 5 p.m.

prnewswire.com - 2026-07-08 07:00:00

Whatfix and PTC Partner to Improve PLM Adoption for Modern Manufacturers

The partnership positions Whatfix as the only global leader in agentic digital adoption platform  partnering with PTC to empower manufacturers to improve software adoption, accelerate new feature discovery & usage, and maximize ROI across PLM environments. SAN JOSE, Calif.

prnewswire.com - 2026-07-07 07:00:00

PTC: An Undervalued Digital Moat In Industrial Software

PTC Inc.'s software suite, specifically Creo for computer-aided design (CAD) and Windchill for product lifecycle management (PLM), serves as the foundational architecture for physical R&D workflows. This structural lock-in is verified by a massive 27% year-over-year increase in Remaining Performance Obligations (RPO). A highly secure 95% of total revenue is entirely recurring in nature.

seekingalpha.com - 2026-07-03 10:01:41

Is It Too Late to Buy PTC Inc (PTC) After 4.0% Rally? GF Value Says Undervalued

On July 02, 2026, PTC Inc (PTC) shares rose 4.0% today, closing at $124.54. Despite this increase, the stock has experienced a volatile year with a 52-week rang

gurufocus.com - 2026-07-02 20:33:00

Vishay Intertechnology SMD Polymer PTC Thermistors Deliver Fast Resettable Overcurrent Protection While Improving Efficiency

Space-Saving Devices Offer High Holding Current to 5.0 A, Fast Trip Times Down to 50 ms, and Low Resistance Down to 5 mΩ in Six Compact Case Sizes Space-Saving Devices Offer High Holding Current to 5.0 A, Fast Trip Times Down to 50 ms, and Low Resistance Down to 5 mΩ in Six Compact Case Sizes

globenewswire.com - 2026-06-30 11:00:00

Is the Options Market Predicting a Spike in PTC Stock?

Investors need to pay close attention to PTC stock based on the movements in the options market lately.

zacks.com - 2026-06-29 12:25:19

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

WARREN, N.J., June 17, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on June 11, 2026, the company approved non-statutory stock options to purchase an aggregate of 10,050 shares of its common stock and 11,870 restricted stock units ("RSUs"), each representing the right to receive one share of its common stock upon vesting, to 18 new employees.

prnewswire.com - 2026-06-17 16:30:00

Orbit Makes PTC's Recent Pullback Interesting Despite Execution Risks

PTC Inc. still has a steady and recurring lifecycle software base with offerings across CAD, PLM, ALM, SLM, and general SaaS workflows. Their newer offerings, like Orbit and Jetstream, also move PTC towards a clearer AI integration path for its products and services. I do believe the sale of Kepware and ThingWorx changed its prospects a bit. In part, it streamlined PTC's business and helped finance stock buybacks.

seekingalpha.com - 2026-06-16 16:48:11

PTC Therapeutics Announces Pricing of Convertible Notes Offering to Refinance 2026 Convertible Notes

– Refinancing transaction with proceeds to be utilized to repurchase or repay the 2026 convertible notes prior to or at maturity – – Offering made at 0% interest with conversion price of $107.48, a 40% premium over the closing price on June 15, 2026 – WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced the pricing of $500.0 million aggregate principal amount of 0% Convertible Senior Notes due 2031 (the "Notes") in a private placement (the "Offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").

prnewswire.com - 2026-06-15 23:14:00

PTC Therapeutics Announces Proposed Convertible Notes Offering to Refinance 2026 Convertible Notes

– Proceeds to be used to repurchase or repay 2026 convertible notes prior to or at maturity – – Offering to include buyback of common stock – WARREN, N.J., June 15, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced that it intends to offer, subject to market conditions and other factors, $500.0 million aggregate principal amount of Convertible Senior Notes due 2031 (the "Notes") in a private placement (the "Offering") to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").

prnewswire.com - 2026-06-15 07:00:00

PTC Launches PTC Orbit, an AI-Powered As-Maintained System of Intelligence for Manufacturers

Enables a complete system of record for asset data, connecting and contextualizing information from various enterprise systems such as PLM, ERP, CRM, IoT, EAM, and FSM systems into a single, unified asset view Built AI-first to surface failure patterns, fleet-level insights, and quality signals that engineering and quality teams can't access today Enables users to explore asset data, investigate issues, and drive action to support reliability and revenue-focused campaigns BOSTON, June 11, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the PTC Orbit™ cloud-native asset intelligence solution, which closes the gap between the product as designed and the asset as maintained. By connecting PLM, ERP, CRM, IoT, EAM, and FSM systems into a single, unified asset record, PTC Orbit applies AI to make asset information accessible, explorable, and actionable across engineering, quality, and service teams and extends the value of the Intelligent Product Lifecycle.

prnewswire.com - 2026-06-11 08:30:00

PTC Unveils a Wave of Product Innovations to Give Manufacturers New AI Capabilities and Connected Tools Across the Intelligent Product Lifecycle

Introduces PTC Orbit and PTC Jetstream, a new AI platform, 12 AI agents, 10 new integrations, and 100+ enhancements across CAD, PLM, ALM, and SLM solutions Delivers the Intelligence Layer across the portfolio, giving manufacturers a stronger foundation for product data, deeper AI capabilities, and a more connected Intelligent Product Lifecycle PTC NEXT provides comprehensive portfolio updates twice a year, giving customers a predictable cadence to stay ahead and move forward with building their Intelligent Product Lifecycle CHICAGO, June 10, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced its latest wave of product innovations to help customers move faster, build smarter products, and unlock more value from their data. Unveiled this week at the PTC NEXT™ Chicago event, the innovations include two new cross-portfolio products, a new AI platform, 12 new AI agents, 10 new integrations, and major updates to every product in PTC's portfolio, further advancing its Intelligent Product Lifecycle vision in ways customers can act on today.

prnewswire.com - 2026-06-10 10:21:00

PTC Brings AI-Powered Guidance to the Design Environment with Creo 13

AI Assistant provides engineering guidance, best practices, and troubleshooting information, reducing onboarding time and reliance on external documentation Beta: AI that reads your 3D model to help teams catch issues earlier and validate designs faster Hundreds of enhancements across design, simulation, and manufacturing, reducing repetitive work and enabling accelerated workflows BOSTON, June 10, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the release of Creo 13 and Creo+ 13.3, the latest versions of its on-prem and SaaS Creo® computer-aided design (CAD) solution. The release introduces the Creo AI Assistant, along with hundreds of enhancements across model-based product development, simulation-driven design, and manufacturing, to help engineering teams deliver better designs in less time.

prnewswire.com - 2026-06-10 08:30:00

Why Is PTC Inc. (PTC) Down 6% Since Last Earnings Report?

PTC Inc. (PTC) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-06-05 12:36:36

PTC Inc (PTC) Stock Up 4.6% and Still Undervalued -- GF Score: 86/100

On June 01, 2026, PTC Inc (PTC) shares rose 4.6% today, closing at $145.08. This move comes amid a 52-week range that has seen a high of $219.69 and a low of $1

gurufocus.com - 2026-06-01 19:38:00

Digital Twin Market Expected to Reach US$ 140 Billion by 2031

New York, May 29, 2026 (GLOBE NEWSWIRE) -- The Insight Partners published its latest market intelligence report on the Global Digital Twin Market. The study finds the market, valued at US$ 13,739. 99 million in 2024, is projected to reach US$ 140,938.

globenewswire.com - 2026-05-29 09:00:44

Digital Twin Market Expected to Reach US$ 140 Billion by 2031

New York, May 29, 2026 (GLOBE NEWSWIRE) -- The Insight Partners published its latest market intelligence report on the Global Digital Twin Market . The study finds the market, valued at US$ 13,739.99 million in 2024, is projected to reach US$ 140,938.14 million by 2031, registering a compound annual growth rate (CAGR) of 40% over the 2025 - 2031 forecast period.

globenewswire.com - 2026-05-29 09:00:00

PTC Partners with TRD U.S.A. to Advance High-Performance Engine Development

PTC named Official Engine Design Software Partner of TRD Creo CAD and Windchill PLM are designated solutions for design and development of TRD's high-performance engines Creo CAD and Windchill PLM enable advanced engineering capabilities, efficiencies, and speed to market BOSTON, May 28, 2026 /PRNewswire/ --  PTC (NASDAQ: PTC) today announced that it was named the Official Engine Design Software Partner of TRD U.S.A. (Toyota Racing Development).

prnewswire.com - 2026-05-28 08:30:00

PTC's Codebeamer Powers Mazda's Software-Defined Vehicle Development

Mazda selects Codebeamer ALM solution to help strengthen requirements management, improve quality, support compliance, and accelerate innovation for software-defined vehicle development Maintains connectivity to Mazda's advanced Model-Based Development (MBD) Establishes foundation for integrated product development and future AI-enabled workflows BOSTON, May 21, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Mazda Motor Corporation, a leading global automaker, has selected the PTC Codebeamer® Application Lifecycle Management (ALM) solution to support its software-defined vehicle development (SDV). Mazda will use Codebeamer to standardize requirements, testing, and validation, enabling end-to-end traceability and faster product development while meeting automotive standards.

prnewswire.com - 2026-05-21 08:30:00

PTC Inc. (PTC) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript

PTC Inc. (PTC) Presents at J.P. Morgan 54th Annual Global Technology, Media and Communications Conference Transcript

seekingalpha.com - 2026-05-19 17:20:55

PTC for Startups Program Helps Companies Design, Produce, and Launch Next-Generation Products

Free access to Onshape, Creo+, Codebeamer+, and a startup package for Arena to manage every stage of the product lifecycle from design and development through compliance and launch Annual renewals available to support startups through key funding and revenue milestones Exposure to PTC's global ecosystem to support industry visibility BOSTON , May 13, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the expansion of its startup program to companies across all industries, extending a model that began with its Aerospace and Defense Startup Program, launched in 2025. Building on that program's success, PTC for Startups now makes PTC's professional-grade product development tools available to qualifying early and growth-stage startups worldwide — at no cost.

prnewswire.com - 2026-05-13 08:30:00

PTC Onshape Introduces Direct Altium Integration to Streamline ECAD-MCAD Collaboration

Connects Printed Circuit Board (PCB) design from Altium directly into Onshape in a unified cloud-native workflow Eliminates file-based PCB data exchange between electrical and mechanical design Streamlines inclusion of detailed components in your personal or company library BOSTON, May 12, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced a new integration between its cloud-native Onshape® computer‑aided design (CAD) and product data management (PDM) platform and Altium. The connector enables electrical and mechanical engineering teams to collaborate more effectively by bringing Printed Circuit Board (PCB) designs directly into Onshape and keeping changes synchronized across both platforms.

prnewswire.com - 2026-05-12 08:30:00

PTC Therapeutics: Sephience Turns The Story From Regulatory Repair To Operating Leverage

PTC Therapeutics is transitioning from a legacy rare disease business to a growth-focused model, anchored by the successful Sephience launch. Sephience's rapid commercial uptake is offsetting DMD franchise declines, with Q1 2026 product revenue up 47% year-over-year and strong patient onboarding momentum. PTCT's partnership with Novartis on votoplam for Huntington's disease offers de-risked late-stage upside, while a $1.9B cash position provides strategic flexibility and reduces near-term dilution risk.

seekingalpha.com - 2026-05-09 23:21:35

PTC Therapeutics Q1 Earnings Call Highlights

PTC Therapeutics NASDAQ: PTCT reported a record first quarter for product revenue and raised its 2026 revenue outlook, citing strong early demand for Sephience, its treatment for phenylketonuria, or PKU.

marketbeat.com - 2026-05-08 17:08:35

PTC Therapeutics Provides Corporate Update and Reports First Quarter 2026 Financial Results

– First quarter 2026 total revenue of $273 million, including $226 million of product revenue, supporting full-year 2026 guidance raise –    – Global Sephience™ (sepiapterin) launch momentum continues with first quarter 2026 revenue of $125 million, representing 36% quarter-over-quarter growth – – Positive topline results from 24-month interim analysis of PIVOT-HD extension study of votoplam, supporting ongoing global Phase 3 INVEST-HD study and potential regulatory interactions – – Open-label vatiquinone registration study to be initiated in Q3 2026 based on FDA feedback – WARREN, N.J., May 7, 2026 /PRNewswire/ -- PTC Therapeutics, Inc., (NASDAQ: PTCT) today announced a corporate update and financial results for the first quarter ended March 31, 2026.

prnewswire.com - 2026-05-07 16:01:00

PTC Q2 Earnings & Revenues Beat on AI-Led ARR Strength, Shares Jump

PTC jumped in pre-market trading after fiscal Q2 2026 revenue rose 22% and AI-driven product demand fueled stronger ARR growth and buybacks.

zacks.com - 2026-05-07 11:51:09

PTC Stock Surges Over 7% Overnight: Why Is It Moving?

PTC shares jumped 7.53% in after-hours trading after the company beat Q2 fiscal 2026 revenue estimates by 8.63% and EPS expectations by 33.83%.

feeds.benzinga.com - 2026-05-06 23:03:30

PTC Inc. (PTC) Q2 2026 Earnings Call Transcript

PTC Inc. (PTC) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-05-06 21:41:17

Here's What Key Metrics Tell Us About PTC Inc. (PTC) Q2 Earnings

While the top- and bottom-line numbers for PTC Inc. (PTC) give a sense of how the business performed in the quarter ended March 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

zacks.com - 2026-05-06 19:01:09

PTC Inc. (PTC) Surpasses Q2 Earnings and Revenue Estimates

PTC Inc. (PTC) came out with quarterly earnings of $2.69 per share, beating the Zacks Consensus Estimate of $2.06 per share. This compares to earnings of $1.79 per share a year ago.

zacks.com - 2026-05-06 18:25:35

PTC lifts annual revenue forecast on steady software demand

PTC Inc on Wednesday raised its full-year revenue forecast, citing continued demand from manufacturers ​using its software to digitize their design ‌and production processes.

reuters.com - 2026-05-06 16:56:05

PTC ANNOUNCES SECOND FISCAL QUARTER 2026 RESULTS

Strategic focus on Intelligent Product Lifecycle vision Solid execution in Q2'26 Constant currency ARR growth of 8.5% excluding divested businesses Operating and free cash flow growth of 14% ~$625 million of cash used for repurchases in Q2'26; targeting repurchases of ~$1.225 billion to ~$1.325 billion in FY'26; New $2 billion share repurchase authorization effective for FY'27-FY'28. BOSTON, May 6, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its second fiscal quarter ended March 31, 2026.

prnewswire.com - 2026-05-06 16:01:00

PTC's Windchill PLM designated by U.S. Army as its Official Enterprise Product Data Management (ePDM) Solution

Windchill enables enterprise-scale digital engineering from acquisition to sustainment Streamlines governance and supports modernization, increases availability of essential mission-critical data Allows for identification of cost-reduction opportunities BOSTON, May 6, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the U.S. Army has designated the Windchill® product lifecycle management (PLM) solution as its official Product Data Management (PDM) and Product Lifecycle Management (PLM) platform. The U.S. Army, through a DEVCOM‑led initiative, is advancing a modern PLM environment to improve the management, governance, and reuse of authoritative product data across the Army enterprise.

prnewswire.com - 2026-05-06 08:30:00

PTC to Release Q2 Earnings: Here's What Investors Should Expect

PTC heads into Q2 earnings with double-digit revenue and EPS growth expectations, strong ARR momentum and expanding AI-driven product capabilities.

zacks.com - 2026-05-05 12:00:44

PTC Codebeamer Replaces Legacy System at Hamilton Medical

Collaboration agreement formed to advance market-specific ALM-PLM solutions Codebeamer ALM solution selected to enhance collaboration, validation, traceability, and regulatory compliance across product development workflows Multi-year collaboration aims to advance PTC's ALM and PLM market-specific capabilities BOSTON, May 5, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that Hamilton Medical, a global leader in intelligent mechanical ventilation solutions, selected PTC's Codebeamer® Application Lifecycle Management (ALM) solution to replace its legacy ALM system and paper-based processes. Further, PTC and Hamilton Medical, a long-term user of PTC's Windchill® Product Lifecycle Management (PLM) solution, have agreed to collaborate to strengthen mutual outcomes.

prnewswire.com - 2026-05-05 08:30:00

PTC Therapeutics to Participate in Upcoming Investor Conferences

WARREN, N.J., May 4, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Bank of America Securities Health Care Conference 2026 Tuesday, May 12 at 8:40 a.m.

prnewswire.com - 2026-05-04 08:00:00

PTC Therapeutics Stock Sinks As Pivotal Data Fails To Calm Sellers

PTC Therapeutics Inc. (NASDAQ:PTCT) shares are tumbling on Wednesday, after the company reported topline results from the 24-month interim analysis of its PIVOT-HD long-term extension study.

benzinga.com - 2026-04-29 14:48:28

PTC Therapeutics Reports Positive Topline Results from Month 24 Interim Analysis of PIVOT-HD Extension Study of Votoplam

- Dose-dependent benefit on cUHDRS in Stage 2 participants compared to matched natural history cohort, with 52% slowing at 10 mg dose - - Continued evidence of favorable safety profile -  - Novartis initiated global Phase 3 INVEST-HD study of votoplam - - PTC will host a conference call to discuss results today, April 28, at 4:30 pm ET -  WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today reported positive topline results from the 24-month interim analysis of the PIVOT-HD long-term extension study, with favorable dose-dependent effects on disease progression for Stage 2 Huntington's disease (HD) patients following 24 months of votoplam treatment compared to an external natural history cohort.

prnewswire.com - 2026-04-28 16:05:00

PTC Therapeutics to Report Results from PIVOT-HD Long Term Extension Study

WARREN, N.J., April 28, 2026 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call today, April 28 at 4:30 p.m.

prnewswire.com - 2026-04-28 09:28:00

PTC Launches Windchill AI Assistant to Simplify How Teams Find and Leverage Product Data Across the Enterprise

Allows users to ask questions in natural language to quickly find answers through an embedded chat interface Helps teams save time by summarizing and surfacing key details from product documents Applies AI to existing Windchill data while maintaining security and access controls BOSTON, April 28, 2026 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced the release of Windchill AI Assistant, a new artificial intelligence (AI) capability built in its Windchill® product lifecycle management (PLM) solution. This new capability introduces generative AI into Windchill via a natural language chat interface, making it easier for users to find, understand, and work with critical product information already stored in the platform, reducing time spent searching and enabling increases in team productivity.

prnewswire.com - 2026-04-28 08:30:00

Get PTC Insider Trade Alerts

PTC Price Target Summary

Last Month

$150.00

1 analysts

Last Quarter

$166.60

5 analysts

Last Year

$190.00

14 analysts

All Time

$179.79

33 analysts

PTC Recent Analyst Grades

Date Analyst Firm Action Previous Grade New Grade
2026-07-13 Barclays Maintain Overweight Overweight
2026-05-08 Citigroup Maintain Neutral Neutral
2026-05-07 Barclays Maintain Overweight Overweight
2026-05-05 Rosenblatt Maintain Buy Buy
2026-04-29 Citigroup Maintain Neutral Neutral
2026-03-23 Mizuho Maintain Neutral Neutral
2026-03-18 Rosenblatt Maintain Buy Buy
2026-03-17 Keybanc Maintain Overweight Overweight
2026-02-06 Citigroup Maintain Neutral Neutral
2026-02-05 Rosenblatt Maintain Buy Buy
2026-02-05 RBC Capital Maintain Outperform Outperform
2026-02-02 JP Morgan Downgrade Neutral Underweight
2026-01-28 Citigroup Maintain Neutral Neutral
2026-01-28 Oppenheimer Maintain Outperform Outperform
2026-01-27 Rosenblatt Maintain Buy Buy